What is your first line strategy for TP53 mutant AML?
1 Answers
Mednet Member
Medical Oncology · Taussig Cancer Institute
I think most would avoid induction-like chemotherapy opting for new regimens such as azacitidine + venetoclax. However, in many instances, the mutation panel comes back after you start treatment which provides a real challenge to use this infuriation in real-time. I hope that faster TAT on NGS panel...